Form 4 for LONA LeonaBio, Inc.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0001209191-22-002218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-06 | 2021-11-18 | LONA | MILESON GLENNA | CFO | A - Grant | $12.51 | +931 | 90.8K | +1% | +$11.6K |
| D | 2022-01-06 | 2022-01-04 | LONA | MILESON GLENNA | CFO | M - OptEx | $1.35 | +6,305 | 97.1K | +7% | +$8,512 |
| D | 2022-01-06 | 2022-01-04 | LONA | MILESON GLENNA | CFO | M - OptEx | $0.00 | -6,305 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | A | A | 931 | $12.51 | 90,755 | D | — | — | (F1) The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of May 18, 2021 through November 18, 2021. This transaction is also exempt under Rule 16b-3(c). (F2) The Purchase Period ended November 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began May 18, 2021. (F3) In accordance with the ESPP, these shares were purchased based on 85% of the closing price on November 18, 2021. |
| 2 | Common | Common Stock | 2022-01-04 | M | A | 6,305 | $1.35 | 97,060 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-01-04 | M | D | 6,305 | $0.00 | 0 | D | $1.35 · — to 2028-12-17 | 6,305 Common Stock | (F4) The shares subject to the option fully vested on January 1, 2022. |